Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Post by RetailRubeon Jun 20, 2013 10:59pm
261 Views
Post# 21552656

Insider Buying

Insider Buying

Dibah, you are correct.  Mr. Frederic Boivin (Senior Director of Finance and Administration) did make two purchases in the open market recently.

 

Mr. Boivin bought a total of 1,500 shares the day after the Annual General Meeting in 2013 for a total cost of $490 plus broker fees.  According to Sedi, this is now his entire holding of his company's stock.

 

Mr. Boivin is paid a salary which is higher than I ever made in one year in my entire career before I retired.  Yet even I consider a $500 trade to be a nuisance trade.  I don't bother with amounts so small.  The company I used to work for had a policy that senior officers had to purchase on the open market company shares valued at 3 times their annual salary.  Our Canadian CEO who moved to NY told me "It really focusses the mind on the success of the business to have to mortgage your house to buy shares."

 

The employees, aside from Dr. Fradet, don't seem to have much faith in the future success of the business.  Too risky for them.

 

<< Previous
Bullboard Posts
Next >>